"UPMC Hillman Cancer Center - Carlisle (Radiation Oncology) in Carlisle, Pa. delivers a full range of cancer care services, from early screening and preventive education to advanced diagnosis, treatment and recovery services. Our multidisciplinary care combines advanced technology, medical expertise and a full range of support services to address body and mind. Caring, experienced cancer care professionals are focused on providing you and your family with exceptional, patient-centered care."

During the past decade, Carlisle Regional Cancer Center conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 1 clinical trials were completed. i.e. 4.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carlisle Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "NRG Oncology" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carlisle Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Carlisle Regional Cancer Center" are "Invasive Breast Carcinoma" (4 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Prostate Adenocarcinoma" (3 trials), "Stage III Lung Cancer AJCC v8" (3 trials) and "Stage IIIA Lung Cancer AJCC v8" (3 trials). Many other conditions were trialed in "Carlisle Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Carlisle Regional Cancer Center" are "Drug" (28 trials), "Other" (22 trials), "Radiation" (15 trials), "Biological" (14 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (16 trials), "Questionnaire Administration" (11 trials), "Computed Tomography" (10 trials), "Magnetic Resonance Imaging" (9 trials) and "Cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Carlisle Regional Cancer Center" are 26 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Carlisle Regional Cancer Center". undefined are not yet recruiting, 22 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Carlisle Regional Cancer Center, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carlisle Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".